Literature DB >> 16860009

Relation of microalbuminuria and coronary artery disease in patients with and without diabetes mellitus.

Rishi Sukhija1, Wilbert S Aronow, Priyanka Kakar, Luis Garza, Rajesh Sachdeva, Anjan Sinha, Jawahar L Mehta.   

Abstract

Microalbuminuria (MA) is a well-known risk factor for coronary artery disease (CAD) in diabetics and nondiabetics. It is associated with higher cardiovascular mortality, especially in diabetics. However, there are few data linking angiographic severity of CAD to microalbuminuria. We examined coronary angiograms for extent of severe CAD (luminal narrowing > or = 50%) in patients with type 2 diabetes mellitus (DM) and MA (DM+MA+, n = 101), patients with DM and without MA (DM+MA-, n = 101), patients without DM and with MA (DM-MA+, n = 64), and patients without DM and MA (DM-MA-, n = 64). We also evaluated fasting glucose levels in all patients and glycosylated hemoglobin in diabetics. Patients' mean age in the DM+MA+, DM+MA-, DM-MA+, and DM-MA- groups was similar. Gender distribution across the 4 groups was also not significantly different. There were no significant differences in the prevalence of hypertension, hypercholesterolemia, and current smoking across the 4 groups. The presence of 2- or 3-vessel CAD showed a linear increase from group DM-MA- to group DM+MA+ (p < 0.001). Diabetics with MA had higher fasting glucose and glycosylated hemoglobin levels than diabetics without MA (p < 0.001). Thus, patients with MA have more severe angiographic CAD than those without MA. This relation is independent of other risk factors and is particularly evident in patients with DM.

Entities:  

Mesh:

Year:  2006        PMID: 16860009     DOI: 10.1016/j.amjcard.2006.01.098

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  12 in total

Review 1.  Type 2 diabetes and cardiovascular disease: Have all risk factors the same strength?

Authors:  Iciar Martín-Timón; Cristina Sevillano-Collantes; Amparo Segura-Galindo; Francisco Javier Del Cañizo-Gómez
Journal:  World J Diabetes       Date:  2014-08-15

2.  Albuminuria, impaired kidney function and cardiovascular outcomes or mortality in the elderly.

Authors:  Dena E Rifkin; Ronit Katz; Michel Chonchol; Linda F Fried; Jie Cao; Ian H de Boer; David S Siscovick; Michael G Shlipak; Mark J Sarnak
Journal:  Nephrol Dial Transplant       Date:  2009-12-15       Impact factor: 5.992

3.  Clinical effects of calcium channel blocker and Angiotensin converting enzyme inhibitor on endothelial function and arterial stiffness in patients with angina pectoris.

Authors:  Kye Hun Kim; Myung Ho Jeong; Sook Hee Cho; Jae Youn Moon; Young Joon Hong; Hyung Wook Park; Ju Han Kim; Youngkeun Ahn; Jeong Gwan Cho; Jong Chun Park; Jung Chaee Kang
Journal:  J Korean Med Sci       Date:  2009-04-20       Impact factor: 2.153

4.  Carotid stiffness and microalbuminuria in patients with type 2 diabetes.

Authors:  Wei-Wei Zhan; Yu-Hong Chen; Yi-Fei Zhang; Ying Zhu; Yan-Yan Lin; Xin-Ping Ren; Xiao-Ying Li; Yan-Ping Liu
Journal:  Endocrine       Date:  2009-04-15       Impact factor: 3.633

5.  The association of microalbuminuria with mortality in patients with acute myocardial infarction. A ten-year follow-up study.

Authors:  Mustafa Taskiran; Allan Iversen; Klaus Klausen; Gorm B Jensen; Jan Skov Jensen
Journal:  Heart Int       Date:  2010-06-23

6.  Asymptomatic coronary heart disease in patients with type 2 diabetes with vascular complications: a cross-sectional study.

Authors:  Tetsuro Tsujimoto; Hiroshi Kajio; Yoshihiko Takahashi; Miyako Kishimoto; Hiroshi Noto; Ritsuko Yamamoto-Honda; Munehiro Kamimura; Miyako Morooka; Kazuo Kubota; Takuro Shimbo; Michiaki Hiroe; Mitsuhiko Noda
Journal:  BMJ Open       Date:  2011-01-01       Impact factor: 2.692

7.  Coronary Artery Disease Is a Predictor of Progression to Dialysis in Patients With Chronic Kidney Disease, Type 2 Diabetes Mellitus, and Anemia: An Analysis of the Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT).

Authors:  Marwa A Sabe; Brian Claggett; Emmanuel A Burdmann; Akshay S Desai; Peter Ivanovich; Reshma Kewalramani; Eldrin F Lewis; John J V McMurray; Kurt A Olson; Patrick Parfrey; Scott D Solomon; Marc A Pfeffer
Journal:  J Am Heart Assoc       Date:  2016-04-23       Impact factor: 5.501

8.  Urinary adiponectin excretion: a novel marker for vascular damage in type 2 diabetes.

Authors:  Maximilian von Eynatten; Dan Liu; Cornelia Hock; Dimitrios Oikonomou; Marcus Baumann; Bruno Allolio; Grigorios Korosoglou; Michael Morcos; Valentina Campean; Kerstin Amann; Jens Lutz; Uwe Heemann; Peter P Nawroth; Angelika Bierhaus; Per M Humpert
Journal:  Diabetes       Date:  2009-06-09       Impact factor: 9.461

9.  Central obesity and albuminuria: both cross-sectional and longitudinal studies in Chinese.

Authors:  Wen-Yuan Lin; F Xavier Pi-Sunyer; Chiu-Shong Liu; Chia-Ing Li; Lance E Davidson; Tsai-Chung Li; Cheng-Chieh Lin
Journal:  PLoS One       Date:  2012-12-12       Impact factor: 3.240

10.  Estimated Glomerular Filtration Rate, Proteinuria, and Risk of Cardiovascular Diseases and All-cause Mortality in Diabetic Population: a Community-based Cohort Study.

Authors:  Anxin Wang; Guojuan Chen; Yibin Cao; Xiaoxue Liu; Zhaoping Su; Yanxia Luo; Zhan Zhao; Xia Li; Shuohua Chen; Shouling Wu; Xiuhua Guo
Journal:  Sci Rep       Date:  2017-12-20       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.